MedTrace Logo

Hybrid L24 New Enrollment Post Approval Study

NCT02379819 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2023-03-13

Study results available
· View outcomes & findings →

Summary

This study evaluates the long term safety and effectiveness of the Nucleus Hybrid L24 Implant in a group of newly implanted adults.

Conditions

  • High Frequency Sensorineural Hearing Loss

Interventions

DEVICE

Nucleus Hybrid L24 Implant

Sponsors & Collaborators

  • Cochlear

    lead INDUSTRY

Principal Investigators

  • Brian Kaplan, MD · Greater Baltimore Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2022-04-14
Completion
2022-04-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02379819 on ClinicalTrials.gov